INTRODUCTION
============

Up to now, the acute and chronic effects of the exposure to heavy metals caused by working environments or environmental pollution have been well-known, and general people well recognize the risk of the excessive exposure to heavy metals. However, the effect of the exposure to heavy metals with low concentration as well as high one has been reported, and it tends to strengthen the management of the chronic exposure to low level heavy metals. Thus, U.S. Centers for Disease Control and Prevention (CDC) set 5 μg/dL in blood, which is the top 2.6% of the children from 1\~5 years of age, as a new lead (Pb) reference level by removing the existing reference of blood 10 μg/dL because the evidence of the previous Pb threshold value is insufficient ([@b1-tr-32-057]). In addition, Joint FAO/WHO Expert Committee on Food Additives (JECFA) withdraw the provisional tolerable weekly intake (PTWI) of 25 μg/kg body weight/week, which was the proposed Pb reference in 2010 ([@b2-tr-32-057]). In case of cadmium (Cd), European Food Safety Authority (EFSA) newly proposed PTWI of 2.5 μg/kg body weight/week that the urinary Cd concentration does not exceed 1 μg/g creatinine in 2009 ([@b3-tr-32-057]).

The exposure level of heavy metals of Korean adults tends to decrease every year, but is still high compared with that of foreign countries. According to the first Korean National Environmental Health Survey (KNEHS, 2009\~2011) and the fifth Korea National Health and Nutrition Examination Survey (KNHANES), the blood Pb concentration of Korean adults was 1.77 μg/dL and 2.24 μg/dL for each, and the blood Cd concentration was 1.03 μg/L from KNHANES and the urinary Cd concentration was 0.66 μg/g creatinine from KNEHS ([@b4-tr-32-057],[@b5-tr-32-057]). According to the U.S. NHANES IV (2011\~2012), the American adults aged 19 and over had the blood Pb concentration of 0.97 μg/dL, the blood Cd concentration of 0.28 μg/L, and the urinary Cd concentration of 0.16 μg/g creatinine ([@b6-tr-32-057]). The American values are lower than the Korean ones. In case of German Environment Survey (GerES III), German adults from 18\~69 years of age had the blood Pb concentration of 3.07 μg/L, the blood Cd concentration of 0.44 μg/L, and the urinary Cd concentration of 0.24 μg/g creatinine ([@b7-tr-32-057]). The German values of cadmium are also lower than the Korean ones.

Both Cd and Pb cause the deterioration of tubular function which significantly affects the loss of essential divalent metals. Thus, its health effect should be well managed in addition to the degradation of glomerular function. Most representative and well-known renal tubular biomarkers are N-acetyl-β-D-glucosaminidase (NAG) and β~2~-microglobulin (β~2~-MG). Urinary NAG is the lysosomal enzyme that much exists in proximal kidney tubule. It is very sensitive biomarker that renal tubular impairment can be easily and noninvasively measured at a low cost ([@b8-tr-32-057]). β~2~-MG is a single-chain small polypeptide and is flowed with tubular fluid through glomerular filtration. It is normal that β~2~-MG is reabsorbed in proximal tubule and that its small quantity is excreted. If renal tubular cell is injured, the excretion increases. Thus, β~2~-MG is also used as a biomarker that is highly used, and it is very sensitive ([@b9-tr-32-057]). Even in kidney damage caused by heavy metals such as Pb and Cd, the excretion of urinary NAG and β~2~-MG may increase ([@b10-tr-32-057]).

In relation to this, recently, several epidemiologic studies reported the significant relation between low level urinary Cd caused by environmental exposure instead of occupational exposure and urinary NAG and β~2~-MG in the general population. The range of geometric means of urinary Cd of those studies is 0.6\~4.5 μg/g creatinine ([@b11-tr-32-057]--[@b15-tr-32-057]).

Meanwhile, considering the exposure to heavy metals in reality, it is hard to find the case that human is exposed to only one heavy metal. But under the situation, the studies that apply the exposure to multiple heavy metals have been hardly conducted. Some studies reported the concurrent exposure to heavy metals may have additive or synergistic interaction to glomerular or tubular functional loss, and also some epidemiological studies reported that interaction or, reversely, antagonistic effect ([@b16-tr-32-057]--[@b19-tr-32-057]).

The aim of this study is to find the relation between the low level exposure to Cd and Pb in the general population and urinary NAG and β~2~-MG, and to find the interaction effect when humans are exposed to both two heavy metals.

MATERIALS AND METHODS
=====================

This study was approved by the ethics committee of Dankook University Hospital (DKUHIRB2010-04-0093, DKUHIRB2011-03-0086).

Study participants
------------------

The participants of this study were the people in Korean Research Project on the Integrated Exposure Assessment to Hazardous Materials for Food Safety (KRIEFS), conducted from 2010 to 2012 by Korean Ministry of Food and Drug Safety. This study supplements the shortage of KNHANES and KNEHS, and gives the comprehensive research on dietary intake of many types of noxious substances in addition to heavy metals and the effect on human health specific to those substances. The participants were selected from 15 cities except Jeju-do in Korea. Their selection method was the square root allocation based on the population composition after the allocation of the minimum sample size by region, gender, and age to extract household in 102 *Eups*, *Myeons*, and *Dongs*. Total 4,867 people joined this study. Among them, the number of the people at 19 or higher is 2,118. The participants had physical measurement and examination, and dietary questionnaire was conducted. In addition, their blood, 12-hr urine, and spot urine were collected ([@b20-tr-32-057]).

Measurement of blood Pb and urinary Cd
--------------------------------------

Pb was measured in the blood, and Cd was in the blood and the 12-hr urine. The 12-hr urine was collected from the time after the dinner the day before the survey date to the morning of the survey date. Urine sample was collected by using a plastic cup, put in a plastic bag, and stored in a cool space until the survey morning. The blood sample collected was put in a heavy metal ethylene diamine acetic acid (EDTA) tube and well mixed with anticoagulant. The sample was stored and transported at 4°C.

The analysis of Pb and Cd in the blood was performed by using Graphite Furnace Atomic absorption Spectrometer (GF-AAS) manufactured by Thermo (Cambridge, UK). And the analysis of Cd in the urine was performed by using GF-AAS manufactured by Varian. The sample for the analysis was homogenized by using a roller mixer. With 0.15 mL, the diluted solution of 0.2% Tirton X-100, 1.2 mL and the tertiary distilled water, 0.15 mL, were added and well mixed, and analyzed by using an atomic absorption spectrometer (AAS). For data analysis, the Pb in the blood and the Cd in the urine were used.

Measurement of adverse renal biomarkers: Urinary NAG and β~2~-MG
----------------------------------------------------------------

Urinary NAG activity was measured by using NAG Quantitative Kit (Shionogi, Osaka, Japan). After storing a synthetic substrate solution (1 mL) at 37°C for five minutes, the solution was mixed with the supernatant of the urine samples (50 mL) received after centrifugation. After storing it at 37°C for 15 min, stopping solution (2 mL) was added to and mixed with it. By using a spectrophotometer, its fluorescence intensities were measured with a wavelength of 580 nm ([@b13-tr-32-057],[@b14-tr-32-057]). Urinary β~2~-MG was measured by using Enzygnost β~2~-MG Micro Kit (Behring Institute, Mannheim, Germany). Its method used the principle of solid phase enzyme-linked immunosorbent assay (ELISA). Monoclonal anti-β~2~-MG antibody and anti-2-MG-horseradish peroxidase conjugate solution were used. After that, color intensities were measured with a wavelength of 450 nm by using a spectrophotometer ([@b13-tr-32-057],[@b14-tr-32-057]).

Other covariates
----------------

The height and weight of the participants were directly measured by the researchers of this study to calculate the body mass index. With 18.5, 25, and 30 set as a cut-off value, the participants were divided into four groups. The questionnaires were completed by direct interviews with the researchers. In case of smoking, questions like "Have you smoked five packs of cigarettes (100 cigarettes)?" and "Do you still smoke?" divide into the groups of former smokers, current smokers, and nonsmokers. In case of drinking, for the question of "How often do you have a drink containing alcohol?", there are 5 answers, "Never in 1 year", "Less than once a month", "Once a month", "Two-four times a month", "Two-three times a week", and "Four or more times a week". For household income, the participants were divided into eight groups. For education level, there were nine groups. These were regrouped considering frequency ([Table 1](#t1-tr-32-057){ref-type="table"}). For the past medical history of high blood pressure and diabetes, "Have you every diagnosed the following disease by doctors?" was asked and its answers were "None", "I recovered from the diseases", "I still have the disease". They were re-grouped and divided into dichotomous variables, yes or no.

Statistical analysis
--------------------

The distribution of the gender, age, and other covariates of the participants, which would be included in the main analyses, was examined. We designated predictor variables as Pb in the blood and Cd in the urine, and outcome variables as urinary NAG and β~2~-MG and calculated the geometric mean and standard deviation, median, and 90 percentile of those variables. In addition, the correlation coefficient was calculated through the spearman correlation test to identify the correlation between the four variables. Before identifying the interaction effect between Pb and Cd, we conducted linear regression to identify the association between each heavy metal and urinary creatinine adjusted NAG and β~2~-MG (unadjusted and adjusted for covariates). Finally, we checked interaction effect of two metals in terms of urinary NAG and β~2~-MG. We applied those metals and their interaction term (blood Pb × urinary Cd) in one linear model. To decrease right skewness and improve the explanation of the model, we used the decimal logarithm transformed predictor variables and the outcome variables. And to see the effect of one metal modified by the other, we divided the data by concentration quartile groups of counterpart metal, and in each data we conducted linear regression and checked the coefficient of one. Covariates like gender, age, body mass index (BMI), smoking, alcohol drinking, household income, past medical history for high blood pressure and diabetes were applied to each model for adjusting. All statistical analyses were performed using R ver. 3.1.3.

RESULTS
=======

Among the 2,118 adults who were recruited from 2010 to 2011, after excluding those who have kidney disease (n = 47) and have missing data 1,953 were finally included in our analyses. There is no significant difference between the proportion and number overview of each variable before and after excluding those who have missing values. Men accounted for 43.1% (n = 842) and women for 56.9% (n = 1111) among the participants. Their age ranged from 18 to 83. The average age was 45.5. About 20.0% participants were a current smoker. In terms of the past medical history, 15.2% (n = 297) people had high blood pressure and 5.9% (n = 116) had diabetes. The geometric mean of the Pb concentration in the blood was 2.21 μg/dL (geometric SD = 1.49 μg/dL), and that of the Cd concentration in the urine was 1.08 μg/g cr (geometric SD = 1.98 μg/g cr). The geometric mean of the urinary NAG concentration and that of β~2~-MG concentration were 4.01 Unit/g creatinine (geometric SD = 2.78) and 51.4 μg/g cr (geometric SD = 2.64), respectively. There were lower than the clinically significant level ([Table 1](#t1-tr-32-057){ref-type="table"}).

The correlation between four predictor and outcome variables was identified with the spearman correlation coefficient. The coefficient between Blood Pb and urinary Cd was 0.13 and their correlation was weak. In terms of the correlation between heavy metals and two adverse renal biomarkers, urinary Cd was more positively associated than blood Pb, and the correlation of NAG (r = 0.33) has a higher coefficient than β~2~-MG (r = 0.19) in urinary Cd ([Table 2](#t2-tr-32-057){ref-type="table"}).

In the unadjusted linear regression model, the concentration of the blood Pb and the urinary Cd highly affected both urinary NAG and β~2~-MG. However, in the model after adjusting, each effect was attenuated. However, all models had a positive coefficient value. In case of urinary Cd, the strength of the association was also high after adjusting (urinary NAG: β = 0.44, p \< 0.001; urinary β~2~-MG: β = 0.13, p = 0.002) ([Table 3](#t3-tr-32-057){ref-type="table"}).

Finally, in the linear regression model with blood Pb, urinary Cd, and their interaction term, the positive interactions for the two renal biomarkers were identified. In case of urinary NAG, the synergistic interaction of the two heavy metals was attenuated (β = 0.34, p = 0.082 to β = 0.25, p = 0.196) after adjusting. However, in case of β~2~-MG, the interaction was reinforced (β = 0.66, p \< 0.001 to β = 0.73, p \< 0.001). The interaction effect of the two heavy metals of β~2~-MG was greater than that of NAG ([Table 4](#t4-tr-32-057){ref-type="table"}). In stratified data analyses, we found the effect modification of Pb and Cd exposure through Cd and Pb concentration quartile groups. We could find more eminent increases of effect on β~2~-MG than NAG ([Fig. 1](#f1-tr-32-057){ref-type="fig"}).

DISCUSSION
==========

In brief, the concentrations of blood Pb and urinary Cd were positively associated with urinary NAG and β~2~-MG in general adults. In addition, we identified the synergism between two metals in the concurrent exposure, and that effect was stronger for β~2~-MG. That is, when Pb and Cd were excreted through the kidney, the effect of the injury of renal tubular cells caused by concurrent exposure was larger than the combination of each effect. It can be also thought that the effect of one metal is reinforced as the other metal exposure is increased.

If a human is chronically exposed to heavy metals, they exist in the blood in combination with protein in addition to free form. They are combined with albumin and with the metallothioneins and glutathione in the blood, which are created to prevent the toxicity of heavy metals in liver and kidney cells. Through the filtration in renal glomeruli, they affect the glomerular function, and also are uptaken through sodium-amino acid cotransporter or endocytosis to renal tubular cell. In addition to the free form heavy metals, conjugated forms can be also uptaken in tubular cell and released in the free form, resulting in the damage of the tubular function ([@b10-tr-32-057],[@b21-tr-32-057]).

The mechanism of the reinforcement of the renal tubular effect by the coexposure of Cd and Pb is not yet clearly identified. It is thought that the Pb binding proteins (PbBPs), metallothionein, glutathione, and heat shock protein (HSP) may act as an important regulator ([@b16-tr-32-057]). In addition, the similarity of the mechanisms and the action sites of Cd and Pb also may play a role of their interaction. With the binding with sulfonyl-group containing enzymes, sequentially reactive oxidative stress is generated, resulting in cell injury ([@b17-tr-32-057],[@b19-tr-32-057]).

In multiple linear regression models for one metal effect, the effect of urinary Cd was stronger. Our results are consistent with the result of the previous studies. In particular, in case of β~2~-MG, after adjusted for other covariates the effect of blood Pb in the model almost disappeared (β = 0.01, p = 0.844), but the effect of urinary Cd after adjusted was still strong (β = 0.13, p = 0.002). It supports that β~2~-MG is a more specific biomarker for the Cd effect ([@b17-tr-32-057]). It is also well explained considering the main target organ of Cd is known to kidney.

Several epidemiological studies considering multiple heavy metals exposure in workers were reported. In a study targeting 57 non-ferrous metal smelter workers in France, the co-exposure was considered. The mean of blood Pb was 38.71 μg/dL, and that of urinary Cd was 2.5 μg/g creatinine. They tried to identify the effect of the co-exposure of Pb and Cd on urinary α-glutathione S-transferases (αGST) using two-way ANOVA. αGST was an early marker that exists in the proximal tubule. If it is damaged, that enzymes are discharged to tubular fluid. It was found that the exposure to Pb had a main effect on the people co-exposed. But the interaction between them was not statistically significant ([@b22-tr-32-057]).

In a cross-section study on the co-exposure of Pb and Cd, targeting 122 Belgian metallurgy workers, the study identified the association between those two metal and five renal tubular biomarkers. The median of the urinary Cd of participants was 0.5 μg/g creatinine, and that of the blood Pb was 15.85 μg/dL. They made binary variable about Pb exposure (over 75 percentile or not). It was found that the effect of the Cd in the blood and urine on the urinary NAG was reinforced in highly Pb exposure group, and they had interaction effect (β = 0.39, p = 0.02 for blood Cd × Pb group, β = 0.84, p = 0.001 for urinary Cd × Pb group). In terms of the interaction with β~2~-MG, there was no significant effect ([@b19-tr-32-057]). The result is contrasted with that of our study that we reported the synergistic effect for β~2~-MG. However, in case of NAG, the result is consistent with ours.

In a study targeting Korean 684 lead worker, the association between the exposure to thallium, antimony, Cd and Pb and glomerular filtration rate (GFR) and NAG. The median of urinary Cd, antimony, thallium and blood Pb was 0.83 μg/g creatinine, 0.36 μg/g creatinine, 0.39 μg/g creatinine, and 21.5 μg/dL, respectively. By putting those metals together in multiple linear regression models, it was found that the effect of the one metal was attenuated by other metals' effects, and the author suggest that it is needed to be cautious about the interpretation of the single metal exposure analysis with low concentration. However, this study did not conduct the interaction in detail ([@b23-tr-32-057]).

The effects of multiple metal exposure were also investigated in US general population. In a study, published in 2009, on the interaction effect of reduced estimated GFR (eGFR) (\< 60 mL/min/1.73 m^2^) and microalbuminuria (≥ 30 mg/g creatinine) in case of the co-exposure of blood Cd and blood Pb in U.S. NHANES (1999\~2006) participants, when 2 log-transformed metals were modeled to multiple linear regression with their interaction term, there was a strong interaction with microalbuminuria (p = 0.003), but weak interaction with reduced eGFR (p = 0.17). It is meaningful that the participants of the study were 14,778 American who were exposed to the heavy metals at low level (geometric mean: blood Pb = 1.58 μg/dL, blood Cd = 0.41 μg/L) and have representativeness ([@b17-tr-32-057]). Those two points are the same as in our study. Even though this American study did not use the same renal tubular marker, the result of the synergistic interaction for microalbuminuria supports out research result because microalbuminuria can be a marker that reflects renal tubular impairment.

A study on the interaction of the renal function of Pb and Cd through structural equation modeling (SEM) was preceded. It targeted 7,236 people and also used the U.S. NHANES (1999--2008) data. The median of blood Pb was 1.3 μg/dL, that of blood Cd 0.30 μg/L, and that of urine Cd 0.22 ng/mL. In the modeling, the predicted renal function score represented the four measurements, creatinine clearance, blood urea nitrogen (BUN), serum creatinine, and the ratio of urine albumin to urine creatinine. Serum Cd and serum Pd had synergistic interaction for renal effect ([@b18-tr-32-057]). This result is consistent about glomerular function to the U.S. NHANES study of Navas-Acien *et al*. ([@b17-tr-32-057]).

Our study is the first one that identified the association between low level Pb and Cd exposure and urinary NAG and β~2~-MG through the national wide data that can represent Korea. In addition, we found the interaction effect in co-exposure of those two metals, so can add the evidence on this interaction.

It is very important in public health perspective that the low level exposure to multiple heavy metals has an interaction effect. General population is exposed to heavy metals almost orally. According to the material of Korean Ministry of Food and Drug Safety in 2010, 86.79% people aged between 20 and 64 are exposed to Pb, and as many as 95.5% is to Cd from food. Vegetables and white rice make the largest contribution to the exposure to Pb and Cd, respectively, in food group ([@b24-tr-32-057]). Considering the situation, it can be thought that the low exposure of general population is chronic over a lifetime. If the reduction in the exposure to only one heavy metal by food ingestion decrease the interaction effect of the co-exposure with the others as well as its own adverse effect, it will be economically profitable.

We have several limitations. First this study cannot reflect the effect of the co-exposure of a large number of other heavy metals and noxious substances. Wang and Fowler suggested it needs to introduce the Omics technique that can identify the general exposure and the effect of the exposure on human body ([@b16-tr-32-057]).

Second, our study design is a cross-sectional study. Temporality is not clear, therefore our study cannot represent the causal relationship, but can identify the association. However, as the participants are the group of general people with low exposure, it is hard to say that the subtle renal tubular injury at an early stage increases the body burden of heavy metals.

Third, in terms of the modeling of the interaction effect, we performed statistical analysis and identified the coefficient by just adding interaction term to a linear model. It reflects multiplicative interaction, but is not about additive interaction. Nevertheless, in case of β~2~-MG, p-value was \< 0.001, and NAG was 0.196. It is thought that there is more than additive interaction, but the statistical analysis for the additive interaction of the exposure to the two heavy metals will be helpful to well understand the mechanism of the interaction.

In conclusion, we found that there is an interaction effect of Pb and Cd exposure on urinary NAG and β~2~-MG. More epidemiological studies for the interaction and toxicological studies on the mechanism are needed.
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![Effect coefficient of urinary Cd and blood Pb on urinary NAG and β~2~-MG modified by the concentration of the counterpart metal. The two figures show the β coefficients of urinary Cd (left) and blood Pb (right) on urinary NAG (white rhomb), and β~2~-MG (black square) using the multiple linear regression model adjusted for age, sex, BMI, household income, smoking, alcohol drinking, and past medical history in the data stratified by quartile groups of the concentration of counterpart metal (1Q: 1^st^ quartile group, 2Q: 2^nd^ quartile group, 3Q: 3^rd^ quartile group, 4Q: 4^th^ quartile group).](tr-32-057f1){#f1-tr-32-057}

###### 

General characteristics, blood or urinary heavy metal concentration, and adverse renal effect indicators of study participants

  Total (n = 1953)                                   N      \%     Mean (SD)                                              Median   90^th^ percentile
  -------------------------------------------------- ------ ------ ------------------------------------------------------ -------- -------------------
  **Sex**                                                                                                                          
   Male                                              842    43.1                                                                   
   Female                                            1111   56.9                                                                   
  **Age (Yr)**                                                     45.3 (14.7)                                                     
   \< 25                                             243    12.4                                                                   
   25\~34                                            224    11.5                                                                   
   35\~44                                            432    22.1                                                                   
   45\~54                                            470    24.1                                                                   
   55\~64                                            409    20.9                                                                   
   ≥ 65                                              175    9.0                                                                    
  **BMI (Body mass index, kg/m^2^)**                               24.1 (3.4)                                                      
   \< 18.5                                           56     2.9                                                                    
   18.5\~24.9                                        1188   60.8                                                                   
   25.0\~29.9                                        623    31.9                                                                   
   ≥ 30                                              86     4.4                                                                    
  **Smoking status**                                                                                                               
   Non-smoker                                        1256   64.3                                                                   
   Ex-smoker                                         307    15.7                                                                   
   Current smoker                                    390    20.0                                                                   
  **Alcohol drinking**                                                                                                             
   Never                                             482    24.7                                                                   
   Once or less than once a month                    528    27.0                                                                   
   2\~4 times a month                                460    23.6                                                                   
   More than twice a week                            483    24.7                                                                   
  **Household income (KRW× 10,000)**                                                                                               
   \< 200                                            792    40.6                                                                   
   ≥ 200, \< 300                                     430    22.0                                                                   
   ≥ 300, \< 400                                     327    16.7                                                                   
   ≥ 400                                             404    20.7                                                                   
  **Education level**                                                                                                              
   Below middle school                               584    29.9                                                                   
   Below high school                                 655    33.5                                                                   
   College or higher                                 714    36.6                                                                   
  **Medical history**                                                                                                              
   Hypertension (Yes)                                297    15.2                                                                   
   Diabetes (Yes)                                    116    5.9                                                                    
                                                                                                                                   
  **Blood Pb (μg/dL)**                                             2.21 (1.49)[a](#tfn1-tr-32-057){ref-type="table-fn"}   2.20     3.66
  **Urinary Cd (μg/g creatinine)**                                 1.08 (1.98)[a](#tfn1-tr-32-057){ref-type="table-fn"}   1.14     2.50
  **Urinary NAG activity (Unit/g creatinine)**                     4.01 (2.78)[a](#tfn1-tr-32-057){ref-type="table-fn"}   4.03     14.32
  **Urinary β~2~-microglobulin (μg/g creatinine)**                 51.4 (2.64)[a](#tfn1-tr-32-057){ref-type="table-fn"}   54.44    151.45

Geomatric means and standard deviations were calculated.

###### 

Spearman correlation coefficient between predictor and outcome variables

                                      Blood Pb   Urinary Cd   Urinary NAG   Urinary β~2~-MG
  ----------------------------------- ---------- ------------ ------------- -----------------
  Blood Pb (μg/dL)                    1          \-           \-            \-
  Urinary Cd (μg/g creatinine)        0.13       1            \-            \-
  Urinary NAG (Unit/g creatinine)     0.13       0.33         1             \-
  Urinary β~2~-MG (μg/g creatinine)   0.05       0.19         0.24          1

###### 

Linear regression for each lead, cadmium, and mercury concentrations and each renal impairment indexes

  Predictor variable                                                      Crude model                                                                  Adjusted model[b](#tfn3-tr-32-057){ref-type="table-fn"}                            
  ----------------------------------------------------------------------- ---------------------------------------------------------------------------- --------------------------------------------------------- ---------- ------ ------ ----------
                                                                          Urinary NAG (IU/g creatinine)[a](#tfn2-tr-32-057){ref-type="table-fn"}                                                                                          
  Blood Pb (μg/dL)[a](#tfn2-tr-32-057){ref-type="table-fn"}               0.31                                                                         0.06                                                      \< 0.001   0.09   0.07   0.320
  Urinary Cd (μg/g creatinine)[a](#tfn2-tr-32-057){ref-type="table-fn"}   0.45                                                                         0.03                                                      \< 0.001   0.44   0.04   \< .0001
                                                                          Urinary β~2~-MG (μg/g creatinine)[a](#tfn2-tr-32-057){ref-type="table-fn"}                                                                                      
  Blood Pb (μg/dL)[a](#tfn2-tr-32-057){ref-type="table-fn"}               0.12                                                                         0.06                                                      0.029      0.01   0.07   0.844
  Urinary Cd (μg/g creatinine)[a](#tfn2-tr-32-057){ref-type="table-fn"}   0.24                                                                         0.03                                                      \< .0001   0.13   0.04   0.002

All predictor and outcome variables were decimal logarithm transformed.

Adjusted for age, sex, BMI, household income, smoking, alcohol drinking, past medical history (hypertension, diabetes).

###### 

Multiple linear regression with interaction term between blood lead and urinary cadmium

  Predictor variable                                                         Crude model                                                          Adjusted model[b](#tfn5-tr-32-057){ref-type="table-fn"}                             
  -------------------------------------------------------------------------- -------------------------------------------------------------------- --------------------------------------------------------- ---------- ------- ------ ----------
                                                                             Urinary NAG (IU/g cr)[a](#tfn4-tr-32-057){ref-type="table-fn"}                                                                                           
  Blood Pb (μg/dL)[a](#tfn4-tr-32-057){ref-type="table-fn"}                  0.19                                                                 0.06                                                      \< 0.001   −0.01   0.07   0.918
  Urinary Cd/cr (μg/g creatinine)[a](#tfn4-tr-32-057){ref-type="table-fn"}   0.33                                                                 0.07                                                      \< 0.001   0.35    0.08   \< 0.001
  Interaction                                                                0.34                                                                 0.19                                                      0.082      0.25    0.19   0.196
                                                                             Urinary β~2~-MG (μg/g cr)[a](#tfn4-tr-32-057){ref-type="table-fn"}                                                                                       
  Blood Pb (μg/dL)[a](#tfn4-tr-32-057){ref-type="table-fn"}                  0.06                                                                 0.05                                                      0.298      −0.02   0.07   0.721
  Urinary Cd/cr (μg/g creatinine)[a](#tfn4-tr-32-057){ref-type="table-fn"}   0.02                                                                 0.07                                                      0.768      −0.12   0.08   0.126
  Interaction                                                                0.66                                                                 0.19                                                      \< 0.001   0.73    0.20   \< 0.001

All predictor and outcome variables were decimal logarithm transformed.

Adjusted for age, sex, BMI, household income, smoking, alcohol drinking, past medical history (hypertension, diabetes).
